Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Axogen, Inc.
Report date August 21, 2019 · Filed August 21, 2019
Section 16 reporting ended · disclosed 2019-08-21. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2019 Filed May 17, 2019 01:14 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 20,000 | $22.63 | $452,600.00 |
DisclosureSEC source: 0001104659-19-030080 · a4.xml · nonDerivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,588 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 573 | $17.57 | $10,067.61 |
DisclosureSEC source: 0001179110-19-002055 · edgar.xml · nonDerivative · entry 2 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,588 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:24 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantCommon Stock | 1,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002055 · edgar.xml · nonDerivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,161 F1 · shares: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. F1 · price: This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria. Read SEC document |
| December 27, 2018 Filed Dec 31, 2018 21:34 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantRestricted Stock Units · Derivative | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-014315 · edgar.xml · derivative · entry 2 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 200 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock. F3 · derivative.exercise_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. F3 · derivative.expiration_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. Read SEC document |
| December 27, 2018 Filed Dec 31, 2018 21:34 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantEmployee Stock Option (right to purchase) · Derivative | 800 | $0.00 Strike: $19.17 | $0.00 |
DisclosureSEC source: 0001179110-18-014315 · edgar.xml · derivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 800 shares Expires 2028-12-27 F1 · derivative.exercise_date: All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 1,500 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · derivative · entry 6 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 35,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · derivative · entry 5 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2018-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 104 | $39.55 | $4,113.20 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 4 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,792 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 1,500 | $2.75 | $4,125.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 3 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 2,425 | $39.55 | $95,908.75 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 2 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,396 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 35,000 | $2.74 | $95,900.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 23:54 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015745 · edgar.xml · derivative · entry 2 Hansen David K · CIK 0001362545 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock. F3 · derivative.exercise_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. F3 · derivative.expiration_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 23:54 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantEmployee Stock Option (right to purchase) · Derivative | 8,600 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015745 · edgar.xml · derivative · entry 1 Hansen David K · CIK 0001362545 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 Underlying: Common Stock · 8,600 shares Expires 2027-12-18 F1 · derivative.exercise_date: All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:44 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantEmployee Stock Option (right to purchase) · Derivative | 25,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000081 · edgar.xml · derivative · entry 1 Hansen David K · CIK 0001362545 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.